|
|
|
- Roy Jones
- 10 years ago
- Views:
Transcription
1 /
2 Agenda Reed Tech Company Profile FDA UDI / GUDID Refresher 12 Steps for Accurate GUDID Submissions Reed Tech GUDID Submission Solution Overview Q&A 2
3 Questions Please send questions during the session to Staff via webinar Chat 3
4 Reed Tech Company Profile 4
5 Reed Tech Profile A recognized leader in providing solutions for content and lifecycle management Over 50 years of experience; founded in 1961 Part of the LexisNexis family; a business unit of Reed Elsevier Over 900 employees Contractor to USPTO to process all patent applications and grants Service Provider to over 800 Life Sciences companies, pharmaceutical and medical devices Philadelphia Headquarters Horsham, PA, USA Washington Operations Alexandria, VA, USA ISO Certified since 1998 (9001:2008) HL7 Member since 2005 GS1 Solution Partner 5
6 Reed Tech Pharma Services SPL Preparation, Submission, and Lifecycle Management for Drug Establishment Registration and Drug Product Labeling/Listing Service provider for over 800 pharma companies 4 of the 5 largest pharma manufacturers in the world; large (200+ labels) to small (1 label) Over 33,000 SPLs created since FDA drug mandate in 2005 Most experienced SPL service provider in the industry Global customers Over 70 companies in over 25 countries outside the U.S. FDA Electronic Submissions Gateway (ESG) service ESG WebTrader and AS2 connections Highest volume submitter of pharma SPLs (over 15,000) Over 450 companies Experts in CDER, CBER, and CVM Drug SPLs Data Transformation/Validation SPL Build, ESG Submission, and FDA Acknowledgement SPL Lifecycle Management SPL 6
7 Reed Tech Medical Device Services SPL Preparation, Submission, and Lifecycle Management for Medical Device product publication in FDA s GUDID GUDID solution provider for over 25 manufacturers (to date) 1 of the 3 largest Medical Device manufacturers in the world Submitted over 6,700 Class III SPL records to the GUDID (to date) 100% acceptance (comprehensive pre submission quality check) ~20% of total GUDID records (~33,000)* ~34% of total GUDID records via SPL (~20,000)* Current contracts to submit over 500,000 additional SPL records (to date) (Implantable/Life sustaining/life supporting, Class II, Class I) Experts in CDRH Medical Device UDI SPL Analysis, Data Aggregation/Transformation/Validation SPL Build, ESG Submission, and FDA Acknowledgement GUDID Data Life Cycle Management (SaaS and Outsourced model) SPL * Calculations based upon FDA statistics presented at Clarion UDI Conference, Baltimore, 28 Oct
8 Reed Tech Medical Device Services (continued) FDA Electronic Submissions Gateway (ESG) service Participated in FDA Pilot Submissions Program in 2014 to assist agency in high volume GUDID ESG load testing ESG AS2 connection for automated, bulk SPL submissions FDA Acknowledgment reporting GUDID Publication status (unpublished, grace period, published, off market) Global Roadmap Support customers needs for international UDID submissions as mandated Reed Tech System is designed to readily accommodate: Expanded data set of IMDRF and regional UDID attributes Building UDI submissions per regional specifications Submitting to international regulatory agencies 8
9 FDA UDI / GUDID Refresher Please send questions during the session to Staff via webinar Chat 9
10 FDA UDI Regulation Overview Label UDI (Device Id + Production Id) on Device Label & Pkg UDI in plain-text (human readable) and Automatic Id and Data Capture (AIDC) technology (1D/2D barcode, RFID, near-field communication ) Date Format YYYY-MM-DD ( ) Direct Marking (DM) Multiple use and reprocessed devices Permanently mark UDI on device FDA Global UDI Database (GUDID) Submit DI and device attributes Public access, global model GUDID Reporting include UDI as available 10
11 UDI on Label vs. GUDID Submission Data Definitions UDI = Device Identifier + Production Identifier(s) = DI + PI(s) GUDID Data = DI (not PI) + Device Attributes = 55 Submitted Fields 11
12 FDA UDI Compliance Timeline 12
13 Recent UDI Regulatory News FDA Advice to Industry FDA GUDID Guidance for Industry Structured input via the GUDID Web Interface requires manual data entry and is geared for low volume submitters. Health Level 7 (HL7) Structured Product Labeling (SPL) submission via the FDA Electronic Submissions Gateway (ESG) allows for submission via xml files and is geared for high volume submitters. Indira Konduri: Build data quality into all tenets of your process as you get organized for GUDID submission. FDA Industry Letter Dated FDA s experience and feedback from industry indicate that device labelers often take a number of actions related to organizing, collecting and validating data before they get a GUDID account or submit device identifier (DI) records. We strongly encourage all device labelers to take such actions to ensure their readiness to meet UDI requirements and streamline the GUDID submission process. FDA to accept GUDID account requests for I/LS/LS Labelers on (Class II later in 2015) FDA UDI Extensions Single Use Implants that are sterilized before use 1 year Label Extension to ; GUDID Submission date remains
14 12 Steps for Accurate GUDID Submissions Please send questions during the session to Staff via webinar Chat 14
15 Survey Results Your GUDID Submission Status What device classes does your organization manufacture (select all that apply)? (286 responses) How far along are you in identifying, collecting and organizing the UDI data that you will need to submit to the FDA GUDID? (286 responses) If you are submitting I/LS/LS UDI data to the FDA, and taking into consideration the September 24, 2015 deadline, when are you anticipating making your submissions? (268 responses) If you are submitting Class II UDI data to the FDA, and taking into consideration the September 24, 2016 deadline, when are you anticipating making your submissions? (239 responses) 15
16 12 Steps Summary UDI Prep 1. Create UDI Governance Team 2. Research/Identify FDA UDI Requirements for Your Products 3. Evaluate Your Situation 4. Define and Implement UDI Labeling Plan GUDID Prep 5. Evaluate, Select, and Implement GUDID Solution 6. Create FDA Accounts (GUDID, ESG) 7. Collect Source GUDID Data 8. Normalize and Validate Source GUDID Data Production 9. Submit GUDID Data to FDA 10. Process ACK Messages 11. Initiate & Maintain Data and System 12. International Readiness 16
17 Step 1 Create UDI Governance Team Product Design Label, DM Financial Mfg Funding, Budget UDI Label, DM Governance Marketing Publish, Order Mgmt Analysis, Planning, Roadmap Regulatory Production Control MDM, Inventory, Supply Chain Data is most likely in disparate systems Collect and Submit Data to FDA All data may not be in accessible electronic format 17
18 Step 2 Research/Identify FDA UDI Requirements for Your Products Research FDA UDI Final Rule and Guidance relevant to Your Products Identify your Product Class(es), Timing/Extensions, Exceptions, Direct Marking, etc. UDI Final Rule Final GUDID Guidance for Industry GUDID Data Elements Reference Table SPL Implementation Files Check UDI Activity in Industry Associations 18
19 Step 3 Evaluate Your Situation Evaluate your Data Situation Data location, gaps, owners, formats, etc. Evaluate Internal Standards Product Identification / Batch / Serialization Issuing Agency (GS1, HIBCC, or ICCBBA) for Product Identification UDI Formats by FDA Accredited Issuing Agency Evaluate Systems Existing MDM, Labeling System, etc. Existing AIDC Technology (1D, 2D, etc.) for UDI Presentation on Label Evaluate Processes Workflow Compliance Documentation Training 19
20 Step 4 Define and Implement UDI Labeling Plan Plan and Implement UDI Labeling (and Direct Marking) Process Revise Production Systems, e.g., MDM, ERP, PLM, Labeling, Inspection, Supply Chain Initiate Product / Batch / Serialization Identification Process Select and implement Issuing Agency (GS1, HIBCC, or ICCBBA) standard Assign Device Identifiers to Products (Primary, Secondary, Unit of Use, Direct Marking, Package Levels) Assign Production Identifiers to Batch / Lot / Serialization (ensure uniqueness) Implement AIDC Technology (1D, 2D, etc.) for UDI Presentation Revise Labels: add Human Readable UDI, AIDC UDI, and Dates to templates Ensure dynamic data flows from production system to product label If Direct Marking is required, redesign product label Perform necessary System Validation and Training Create necessary Documentation (DHF, SOPs, Work Instructions, etc.) 20
21 Step 5a Evaluate, Select, and Implement GUDID Solution 21
22 Step 5b Evaluate, Select, and Implement GUDID Solution Choose Submission Method 22 * SaaS Software as a Service
23 Step 5c Evaluate, Select, and Implement GUDID Solution Submission Method Comparison Submission Method Description/Comments Technology Cost Operations Cost FDA GUDID Web Interface You (or third party) enter data directly into the FDA GUDID Best suited for low volume Transcription error concern Limited international reuse No software cost Your admin, data entry, & QA labor Internal Software Buy / build / upgrade software (ERP, PLM, MDM, Labeling or other) to collect data and build SPLs Submit SPLs to FDA via the ESG (AS2) Own software (buy/build/upgrade, install, validate, train, maintain) ESG account (AS2) Your admin & operations labor Hosted Software (Software as a Service) Use external software to collect data, build, and submit SPLs to FDA via the ESG High volume submissions Rent software Your admin & operations labor Outsourced Service External provider accepts your data, builds, and submits SPLs to FDA via the ESG on your behalf 23 Rent software No internal Admin & operations labor Service cost
24 Step 5d Evaluate, Select, and Implement GUDID Solution Select and Implement Method Selection Considerations Solution Capabilities, Expertise, and Experience SPL Data Validation Controlled Vocabularies FDA ESG Submission ACK Processing and Reporting On going Data Management (ease and capability) Future Proof Scalable International capabilities 21 CFR Part 11 Compliance (not relevant for FDA GUDID Web Interface) Cost Effective Implement Chosen Solution 24
25 Survey Results Your GUDID Solution Preferences Have you decided what method you will use to submit your UDI data to the GUDID? (274 responses) If yes, which of the following methods do you prefer? (224 responses) 25
26 Step 6a Create FDA Accounts (GUDID, ESG) Request GUDID Account Form GUDID Pre Production Account Set Up Process Request a Pre Production (Test) GUDID Account Request Form from the FDA aludidatabasegudid/default.htm#account 26
27 Step 6b Create FDA Accounts (GUDID, ESG) Complete and Submit GUDID Account Form GUDID Pre Production Account Set Up Process Complete the GUDID Account Request Form (Identify Labeler DUNS Numbers / Users / Roles) Attachment to from the FDA (top half of page 1; 3 pages total) 27
28 Step 6c Create FDA Accounts (GUDID, ESG) Setup ESG Account ESG Account Set Up Process (if using SPL Submissions) Request ESG Test Account Send Letter of Non Repudiation Obtain and Send a Digital Certificate Register/Launch ESG Test Account Send Test Submissions (connectivity test, compliance test) Apply for ESG Production Account Launch ESG Production Account Note: Reed Tech provides ESG account setup and ESG submission as part of our service at no additional charge 28
29 Step 6d Create FDA Accounts (GUDID, ESG) Test GUDID Pre Production Account using ESG Connection GUDID Pre Production Account Testing Process (if using SPL Submissions) Complete 4 Test Scenarios SPL submission into GUDID obaludidatabasegudid/ucm zip 29 Note: Reed Tech provides SPL Test submissions using our ESG AS2 connection at no additional charge
30 Step 6e Create FDA Accounts (GUDID, ESG) Setup GUDID Production Account GUDID Production Account Set Up Process Request a Production GUDID Account using the same process as the Pre production account Use the same Application Form as before; make any changes necessary for the GUDID Production environment 30
31 Step 7a Collect Source GUDID Data Collect Source Production GUDID data Collect data from multiple sources, such as: Production Systems, e.g., PLM, MDM, ERP Labeling System (label templates, dynamic data) Regulatory Systems If necessary, capture data from Label (e.g., single use icon) Populate (55) GUDID Values into Records Reed Tech GUDID Data Template is available to organize content Merge partial records from multiple data sources If desired, collect additional data fields for your internal purposes and/or future UDI submissions to international Regulatory Authorities 31
32 Step 7b Collect Source GUDID Data GUDID Data (directly) GUDID Data (needs coding) 32 Reference: FDA GUDID GFI Jun
33 Step 7c Collect Source GUDID Data ( Identification Pri DI Issuing Agency Primary DI # Brand Name Version/Model # Catalog # Device Description Sec DI Issuing Agency Secondary DI # DM Exempt (Y/N) DM DI Different (Y/N) DM DI # Labeler Labeler DUNS # Labeler Name* Labeler Address* Contact Phone Contact Regulatory Publish Date Distribution End Date Distribution Status* Premrkt Exempt (Y/N) Premrkt Submission # Supplement # FDA Listing # Product Code Product Code Name* GMDN Code GMDN Name* GMDN Definition* Rx (Y/N) OTC (Y/N) 55 Submitted by Labeler Packaging Device Count Unit of Use DI # Kit (Y/N) Pkg DI # Pkg Quantity Pkg Contains DI # Pkg Type Pkg Discontinue Date Pkg Status* Production Control Lot/Batch (Y/N) Serial # (Y/N) Mfg Date (Y/N) Expiration Date (Y/N) Donation Id # (Y/N) (some can have multiple values) 7 Populated by FDA GUDID System Characteristics Single Use (Y/N) Combo Product (Y/N) HCT/P (Y/N) Contains Rubber (Y/N) Not Made with Rubber (Y/N) MRI Safety Info Size Type Size Value Size Unit Size Text Storage & Handling Type S&H Low value S&H High Value S&H Unit Storage Conditions Sterile Pkg (Y/N) Sterile Req'd Sterile Method * Populated by FDA GUDID System 33
34 Step 8a Normalize & Validate Source GUDID Data Normalize data to FDA GUDID specs Follow FDA Business Rules. For example: GS1 GTINs must be 14 numeric characters Date Format must be YYYY MM DD Where applicable, ensure values utilize Controlled Vocabularies. For example: cm for Size Unit of Measure Cel for Temperature (Degrees Celsius) For grouped data, all necessary related fields must be populated. For example: Clinically Relevant Size Type = Length Clinically Relevant Size Value = 25 Clinically Relevant Size Unit = cm For dependent data, all necessary related fields must be populated. For example: If Require Sterilization prior to use? = Yes, then Sterilization Method must be populated Validation of all content: the key to accuracy for your SPL submissions to the FDA Problematic Data Elements from our experience. For example: Labeler DUNS Numbers Device Identifiers assignment GMDN or FDA Preferred Term Values Packaging and Kit Configurations Data Validation is a Reed Tech core competency we can help 34
35 Step 8b Normalize & Validate Source GUDID Data (available upon request) GUDID Data Record 55 Submitted Data Elements Product ID Elements (Pri DI, Sec DI, UoU DI, DPM DI, GMDN) Regulatory Elements (FDA Listing #, Auth. #, ProCode) Labeler and Contacts Characteristics (Sterile, Size, Production Control) Package Elements (Pkg DI, Qty) 35
36 Step 9 Submit GUDID Data to FDA Go Live Submit Production device records For Manual, Individual Record Entry: Enter data via FDA GUDID Web Interface Perform QC on Data Entry For Automated, Bulk Entry: Create fully valid SPL UDI submissions per FDA business rules Validate SPL XML per FDA schema requirements Submit SPL UDIs to FDA via ESG WebTrader record by record manually driven process AS2 (Applicability Statement 2) communication protocol for automated bulk transfer SPL Validation and ESG Submission are Reed Tech core competencies we can help 36
37 Step 10 Process ACK Messages Applicable to SPL Submissions only Monitor and Collect FDA ACK messages ACK 1 FDA receipt confirmation ACK 2 CDRH receipt confirmation ACK 3 CDRH validation results Pass Fail, explanatory error message provided Report ACKs Indicate GUDID Record Publication Status Unpublished Published, in Grace Period Published Retired (product taken off market) 37
38 Step 11 Initiate & Maintain Data and System Start Manufacturing Confirm Device Record is Published in GUDID Cutover process to include UDI on Label (with direct marking where applicable) Manage existing Inventory within 3 year allowed window Flow DI and PI from production systems to labels Data Maintenance Update/retire Device Labels and GUDID records as appropriate Add Device Labels and GUDID records for new products System Maintenance (for in house software only) Update, Validate, Train, and Document system changes Knowledge Maintenance Monitor and Implement changing FDA Regulations and Guidance (subscribe to FDA UDI/GUDID notifications) 38
39 Step 12 International Readiness International Medical Devices Regulatory Forum (IMDRF) Cornerstone of global medical device regulatory direction Group of Medical Device Regulators (Australia, Brazil, Canada, China, EU, Japan, Russia, U.S.) A single worldwide UDID will not be implemented Per Laurent Selles, Senior Coordinator for International Relations, EC; Munich, May 2014 Regional UDIDs will contain core information and have varying regional content. Convergence, not Harmonization EU Late 2015 / most likely 2016 EU UDI Mandate Other regulatory authorities actively involved in UDI EU Asia (China, Japan, Korea, Singapore) Australia Canada South America (Brazil, Argentina) 39
40 Reed Tech LSP GUDID Submission Solution (SaaS or Outsourced) Please send questions during the session to Staff via webinar Chat 40
41 Reed Tech GUDID SPL Solution (SaaS or Outsourced) 41
42 Reed Tech UDI Solution Benefits Simple Complements your current internal processes SaaS and Outsourced both available Minimally intrusive Accepts data from your existing systems, initially and for subsequent, on going maintenance Flexible data import options: XLS, XML, text file, manual entry Save Time Reed Tech Life Science Portal can help save time during the data collection process Data Transformations per Reed Tech Synonym Vocabulary Data Aggregation Data Collection Assistance available Cost effective Efficient, automated, bulk submissions Save IT costs (e.g., hardware/software purchase, installation, validation, maintenance) 42
43 Reed Tech UDI Solution Benefits (continued) Flexible, Scalable and Future Architected GUDID solution Accommodates additional custom/proprietary data fields beyond FDA requirements Easy expansion for future UDID submissions to global regulatory authorities (EC, PMDA ) Secure, Validated System Secure, environmentally controlled data center System meets all 21 CFR Part 11 technical compliance standards Role based data management and approvals Preparation, submission, and acknowledgement reporting E signature submission approval Gain an experienced corporate partner Over 50 years of knowledge and expertise in data collection, content conversion and validation, submissions, lifecycle management, and excellent customer service 43
44 Reed Tech UDI Resources Available from ReedTech.com: GUDID Readiness Kit free ebook udi readiness kit Reed Tech GUDID Data Element List elements Multiple Options To Weigh For Moving A UDI Into FDA s Database The Gray Sheet 6 January sheet article 0 UDI Training Course (in collaboration with Lernia Training Solutions) Available Upon Request: Sample GUDID Account Request Form Reed Tech GUDID Record Template 44
45 Reed Tech Contact Information Haley Lentz Account Executive, Life Sciences Phone: or Web:
46 Q&A Please send questions to Staff via webinar Chat 46
47 Reference Material 47
48 UDI Resources FDA UDI Home Page UDI Rule, GUID Guidance, Compliance Dates, Resources ntification/default.htm UDI Help Desk ntification/ucm htm GUDID Information Basics, Guidance, Account Request, GUDID Web Interface, HL7 SPL, GUDID Status ntification/globaludidatabasegudid/default.htm GUDID Web Interface (Login) CDRH Resources (FDA Presentations: GUDID overview, account setup, etc.) tification/changesbetweenudiproposedandfinalrules/default.htm IMDRF EC Medical Devices devices 48
49 Medical Device UDI Glossary AIDC DI ESG GUDID GS1 Automatic Id and Data Capture technology used for automated product identification (typically 1D/2D barcode, RFID, near field communication, etc.) Device Identifier static product identification (uniquely identifies company and product version) Electronic Submissions Gateway FDA agency wide secure solution for accepting electronic regulatory submissions in electronic, bulk format FDA Global UDI Database registry of Medical Device DI and attributes GS1 an international, not for profit association that develops global standards (e.g., Global Trade Item Number GTIN and Application Identifiers AI) to improve the efficiency and visibility of supply and demand chains across sectors; Issuing Agency FDA approved agency (standard) used to represent Medical Device UDI (GS1, HIBCC, and ICCBBA) HIBCC Health Industry Business Communications Council a non profit organization that develops electronic exchange standards (e.g., Health Industry Bar Code HIBC) for health care trading partners; HL7 ICCBBA PI SPL UDI XML Health Level Seven standards developing organization providing international healthcare information system interoperability standards for the exchange, integration, sharing, and retrieval of information International Council for Commonality in Blood Banking Automation international standards organization (not for profit, nongovernmental) responsible for the ISBT 128 Standard (International Standard for Blood and Transplant); Production Identifier dynamic manufacturing information (i.e. batch/lot #, serial #, mfg. date, expiration date, and HCT/P code) Structured Product Labeling document markup standard (XML) approved by HL7 and adopted by FDA as a mechanism for exchanging product information Unique Device Identifier = Device Identifier (DI) + PI (Production Identifier) per approved Issuing Agency Extensible Markup Language markup language defining a set of rules for document encoding in both human and machine readable language. 49
50 Global (G)UDID Data Elements 50
Niccolo Machiavelli (1523)
Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of things. For the innovator has for enemies all those
Unique Device Identification Challenges for Manufacturers Focus UDID
Unique Device Identification Challenges for Manufacturers Focus UDID GS1 Healthcare Conference Copenhagen, Oct 22, 2014 Volker Zeinar Global UDI Project Leader FDA s UDI Requirements (Medical Devices)
GS1 STANDARDS & UDI UPDATE SIOBHAN O BARA GS1US
GS1 STANDARDS & UDI UPDATE SIOBHAN O BARA GS1US AGENDA We have the standards. GS1 US Background and Update We have the framework. Unique Device Identification (UDI) We need to move forward. The clock is
UDI. Guide to Label and Marking Compliance. Unique Device Identification. For Medical Device Manufacturers
Final Rule UDI Unique Device Identification For Medical Device Manufacturers Guide to Label and Marking Compliance UDI Unique Device Identification Table of Contents Introduction... 1 Compliance with FDA
UNIQUE DEVICE IDENTIFICATION. and in the European Union. Laurent SELLES Senior Coordinator for International Relations Health Technology and Cosmetics
GLOBAL GS1 HEALTHCARE CONFERENCE Copenhagen Denmark 22 October 2014 UNIQUE DEVICE IDENTIFICATION Situation in the International Medical Device Regulators Forum (IMDRF) and in the European Union Laurent
Global Unique Device Identification Database (GUDID) Guidance for Industry and Food and Drug Administration Staff
Global Unique Device Identification Database (GUDID) Guidance for Industry and Food and Drug Administration Staff Document issued on June 27, 2014. The draft of this document was issued on September 24,
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff
Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Document issued on August 20, 2014. On November 5, 2014 this document was
UDI Regulatory 101. Erin (Fields) Quencer. UDI Conference October 28-29, 2014 Baltimore, MD. October 28, 2014. Regulatory Analyst, FDA
UDI Regulatory 101 October 28, 2014 Erin (Fields) Quencer Regulatory Analyst, FDA Slide 1 Basic UDI Requirements Device label and device package must bear a UDI, 21 CFR 801.20 Devices intended to be used
UDI Systems Comparison Report for Tissue Banks December 20, 2013
This UDI Systems Comparison Report for Tissue Banks provides AATB s membership with an overview of three specific labeling capabilities that will likely be approved by the Food and Drug Administration
IMPLEMENTATION GUIDELINE
IMPLEMENTATION GUIDELINE Using the GS1 System for U.S. FDA Unique Device Identification (UDI) Requirements F O R S U P P L I E R S & R E C E I V E R S R 1. 1 S E P 1 2 2 0 1 4 CONTENTS PART 1: PREFACE...
U.S. FDA Unique Device Identification (UDI) Rule Frequently Asked Questions (FAQs) R 2. 3 -- M A R 1 1 2 0 1 4
U.S. FDA Unique Device Identification (UDI) Rule Frequently Asked Questions (FAQs) R 2. 3 -- M A R 1 1 2 0 1 4 CONTENTS DOCUMENT PURPOSE... 6 GENERAL QUESTIONS ABOUT THE U.S. FDA UDI RULE... 7 1. General...
GUDID Account Request: Preparation and Process
GUDID Account Request: Preparation and Process April 19, 2016 Chris Diamant, UDI Program Analyst Food and Drug Administration Slide 1 The GUDID Data submission required by UDI System Final Rule Submission
FAQ: Unique Device Identification Final Rule
FAQ: Unique Device Identification Final Rule October 2013 Key Changes from Proposed Rule A separate UDI is not required for devices within a convenience kit, regardless of Class designation, so long as
Unique Device Identification Update FDA and GHTF
Unique Device Identification Update FDA and GHTF Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration [email protected] 301-980-1936 UDI Can Improve Visibility Medical device
FDA s Electronic Submissions Gateway (ESG)
FDA s Electronic Submissions Gateway (ESG) April 19, 2016 Presenter: La Misha Fields, Program Manager FDA ESG Slide 1 Agenda What is ESG? ESG Process, Account Types Account Setup and Differences Submission
UDI Implementation Reality AIDC Medical devices: How to identify/mark my products?
UDI Implementation Reality AIDC Medical devices: How to identify/mark my products? UDI Implementation Reality Medical devices: How to identify/mark my products? Moderator Ms. Jackie Rae Elkin Global Process
EHIMA Guidance Document Revision: V05 Issue date: 2016-01-25
Guidance Document for EHIMA labelling of hearing aids and accessories in accordance with UDI Page 1 of 6 1. Scope This EHIMA guidance document is intended to provide guidance to hearing aid manufacturers
Information Management FAQ for UDI
White Paper Information Management FAQ for UDI 20 Questions & Answers about Complying with the FDA Requirement for Unique Device Identification (UDI) This document contains Confidential, Proprietary and
Unique Device. Adoption and Use Trends for Medical Devices. Authors: Anya Kroupnik and Susan Moretti
Unique Device Identifier Study Adoption and Use Trends for Medical Devices Authors: Anya Kroupnik and Susan Moretti May 2013 Unique Device Identifier Study Results Table of Contents SECTION I: Executive
Manufacturer Master Data
Manufacturer Master Data December 1, 2011 Jackie Elkin, Medtronic, Inc. Slide 1 What is Master Data? Master Data, which may include reference data, is information that is key to the operation of business
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE 1 GS1 STANDARDS IN HEALTHCARE Together, we re making it possible to follow drugs and medical devices from the manufacturer
Agenda The emdr Challenge
The emdr Challenge Agenda The emdr Challenge Terminology High-Volume Basic Requirements Low volume Requirements Decision tree high volume vs. low volume Lessons Learned & Tips for Successful emdr Implementation
Unique Device Identification System; Final Rule
4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Unique Device Identification System; Final Rule Docket No. FDA-2011-N-0090 Final Regulatory Impact Analysis Final Regulatory
Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff
Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff Document issued on August 13, 2014 On November 5, 2014 this document was
Implementing a Complaint Management and Reporting System using TrackWise
Implementing a Complaint Management and Reporting System using TrackWise Gambro Use Case Kai Kiefer Manager, IT Center of Excellence ECM & Quality Solutions Gambro Dialysatoren GmbH Yohay Yafe Director,
Takeda UPI Contribution to Conference. Vendor selection process for Serialization and product Tracking. May 2014. Authors: Bahman Didar
Takeda UPI Contribution to Conference Vendor selection process for Serialization and product Tracking May 2014 Authors: Bahman Didar Delivering the Unified Product Identifier Program at Takeda Agenda 1.
AN INTRODUCTION TO THE GLOBAL INDIVIDUAL ASSET IDENTIFIER (GIAI) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Individual Asset Identifier?... 3 What Is a GIAI Used For?... 3 Key Attributes of the GIAI... 3 Business Benefits of Using GIAIs... 3 How Is the GIAI Formed?... 4 Frequently
UNIQUE DEVICE IDENTIFICATION (UDI) FOR MEDICAL DEVICES: ECONOMIC ANALYSIS OF THE FINAL RULE
Task Order No. 30 CONTRACT NO. HHSF223200810017I FINAL REPORT UNIQUE DEVICE IDENTIFICATION (UDI) FOR MEDICAL DEVICES: ECONOMIC ANALYSIS OF THE FINAL RULE SUBMITTED TO: FOOD AND DRUG ADMINISTRATION OFFICE
White Paper Healthcare Supply Chain Traceability
Executive Summary This white paper focuses on Healthcare supply chain Traceability, from manufacture to patient, going beyond, for example, what is currently regulated by the US 21 CFR Part 820 and ISO
How To Serialize
Drug Supply Chain Security Act Compliance Serialization epedigree Challenges and Potential Benefits to Manufacturers Joe Whyte Rockwell Automation Global Serialization Lead E-mail: [email protected]
Medical Device Labeling Overview
Medical Device Labeling Overview Labeling Task Group IOPP Medical Device Packaging Committee October 22, 2003 Opening Slide Forces that drive the move toward bar codes Device Manufacturers use bar codes
Delivering a Comprehensive Serialization Traceability Program Peggy Staver - Pfizer
Delivering a Comprehensive Serialization Traceability Program Peggy Staver - Pfizer Overview Pfizer History What it Takes Strategies Organization Solutions Business-as-Usual Summary April 21, 2015 2 Pfizer
AATB/ICCBBA Interim Guidance Document. For use of ISBT 128 by North American Tissue Banks
AATB/ICCBBA Interim Guidance Document For use of ISBT 128 by North American Tissue Banks Version 1.2.0 September 2012 Published by: ICCBBA PO Box 11309, San Bernardino, California, USA 1.909.793.6516 [email protected]
By Natalia Wilson, MD, MPH
White Paper The value of unique device identification across healthcare By Natalia Wilson, MD, MPH Executive summary The Unique Device Identification (UDI) System Proposed Rule was published by the U.S.
Global Medical Device Nomenclature (GMDN)
Global Medical Device Nomenclature (GMDN) GMDN A Requirement for UDI Mark Wasmuth CEO, GMDN Agency What we will be discussing Why is the GMDN needed GMDN data structure How to find GMDN terms Unique Device
Guidance for Industry
Guidance for Industry Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages FINAL GUIDANCE U.S. Department of Health and Human Services Food
AN INTRODUCTION TO THE GLOBAL DOCUMENT TYPE IDENTIFIER (GDTI) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Document Type Identifier?... 3 What Is a GDTI Used For?... 3 Key Attributes of the GDTI... 3 Business Benefits of Using GDTIs... 4 How Is the GDTI Formed?... 4 Frequently
RFID Survives Sterilization to Deliver Medical Device Tracking Solution
RFID Survives Sterilization to Deliver Medical Device Tracking Solution and UDI Compliance Introduction Healthcare providers are increasingly turning to technology solutions to help improve patient outcomes,
OV E R V I E W A N D G U I D A N C E O N VACC I N E 2 D B A R CO D I N G
Vada Perkins, BSN, MSc, RN CAPT, USPHS, Chief, Business Operations Staff US Food and Drug Administration OV E R V I E W A N D G U I D A N C E O N VACC I N E 2 D B A R CO D I N G "Reviewed April 2013" 2D
Building a Serialization Compliance Management System. Lewis Kontnik, Director Brand Protection Amgen Inc. (Oct. 2012)
Building a Serialization Compliance Management System Lewis Kontnik, Director Brand Protection Amgen Inc. (Oct. 2012) About Amgen Amgen discovers, develops, manufactures, and delivers innovative human
Session 5: Unique Device Identifier ASC X12. Margaret Weiker, ASC X12N Chair
Session 5: Unique Device Identifier ASC X12 Margaret Weiker, ASC X12N Chair LEGAL DISCLAIMER This presentation is for informational purposes only. The content should not be construed as legal advice. If
Major Release 3.1. Global Webinar. 1 October 2015
Major Release 3.1 Global Webinar 1 October 2015 Agenda of Webinar Introduction Maryam Mirza, GS1 Global Office Major Release Status and next steps Mark Widman, GS1 Global Office Abbott Brad Depke ICA Sylvia
UNDERSTANDING THE EC DIRECTIVE 98/79/EC ON IN VITRO DIAGNOSTIC MEDICAL DEVICES
UNDERSTANDING THE EC DIRECTIVE 98/79/EC ON IN VITRO DIAGNOSTIC MEDICAL DEVICES A WHITE PAPER ON THE REQUIREMENTS, REGULATIONS AND OPPORTUNITIES CONTAINED IN EC DIRECTIVE 98/79/EC AND A BRIEF COMPARISON
Establishment Registration SPL Technical Errors Training ebook
Technical Errors Training ebook Interpretations & s for Technical Errors in Establishment Registration SPL Documents Submitted to FDA Version 1.0 Purpose: This SPL training ebook is to be utilized by SPL
The Impact of 21 CFR Part 11 on Product Development
The Impact of 21 CFR Part 11 on Product Development Product development has become an increasingly critical factor in highly-regulated life sciences industries. Biotechnology, medical device, and pharmaceutical
AN INTRODUCTION TO THE GLOBAL TRADE ITEM NUMBER (GTIN) TABLE OF CONTENTS
TABLE OF CONTENTS What Is a Global Trade Item Number?... 3 What Is a GTIN Used For?... 3 Key Attributes of the GTIN... 3 Business Benefits of Using GTINs... 3 How Is the GTIN Formed?... 4 Which GTIN Is
What makes SAP SRM 7.01 impressive? Rakesh Singh, GyanSys Inc. Naveen Rajan, GyanSys Inc.
What makes SAP SRM 7.01 impressive? Rakesh Singh, GyanSys Inc. Naveen Rajan, GyanSys Inc. ] [ Agenda GyanSys Brief Overview SRM 7.01 New Features 7.01 Case Study [ GyanSys Brief Overview Offices Global
2012 GTIN Sunrise Explained IMPLEMENTATION ROADMAP FOR U.S. HEALTHCARE SUPPLY CHAIN MEMBERS
2012 GTIN Sunrise Explained IMPLEMENTATION ROADMAP FOR U.S. HEALTHCARE SUPPLY CHAIN MEMBERS Contents Executive Overview... 4 U.S. Healthcare Industry Sunrise Dates... 5 2012 GTIN Sunrise... 5 Contrast
Pharmaceutical Distribution Security Alliance (PDSA)
Pharmaceutical Distribution Security Alliance (PDSA) Our Mission The Pharmaceutical Distribution Security Alliance's (PDSA) mission is to develop and help enact a federal policy proposal that enhances
UDI as the Cornerstone to Medical Device Data Capture. Presentation to: 27th Global GS1 Healthcare Conference
UDI as the Cornerstone to Medical Device Data Capture Presentation to: 27th Global GS1 Healthcare Conference April 23, 2015 Mexico City The Pew Charitable Trusts Pew is an independent, non-profit research
Roadmap for study startup
How-To Guide Roadmap for study startup Deploying Adobe technology to automate clinical study startup procedures Section 1: Introduction and overview 2 1.1 Introduction 2 1.2 Overview of the clinical study
European Medicines Verification System (EMVS) European Pack Coding Guidelines
European Medicines Verification System (EMVS) European Pack Coding Guidelines June 2013 Revision History V1.0 June 2008 Initial Release V1.1 June 2008 Amended some typographical errors, added extra detail
Implementation strategy for ISO IDMP in EU
Implementation strategy for ISO IDMP in EU Paolo Alcini Head of Data Standardisation and Analytics Business Data & Analytics Information Management EMA An agency of the European Union The EU ISO IDMP Task
The growing sophistication of the master data cleansing service industry
The growing sophistication of the master data cleansing service industry Krishna Shastry CTO, Grihasoft October 16 th, Data Quality Conference Agenda Overview : Data cleansing service industry Need for
Track & Trace Solutions
Track & Trace Solutions Comprehensive Pilot Software Suite From Sensor to and from Carton to Pallet Adaptability Performance & Performance and Security Maximum Adaptability & Performance by Centralized
Best Practices in Identity and Access Management (I&AM) for Regulatory Compliance. RSA Security and Accenture February 26, 2004 9:00 AM
Best Practices in Identity and Access Management (I&AM) for Regulatory Compliance RSA Security and Accenture February 26, 2004 9:00 AM Agenda Laura Robinson, Industry Analyst, RSA Security Definition of
T03 - Serialization. Best Practices in Reducing Risk and Achieving Business Agility PUBLIC
T03 - Serialization Best Practices in Reducing Risk and Achieving Business Agility PUBLIC PUBLIC - 5058-CO900G PUBLIC 2 Agenda What is Serialization Why Serialize The Future of Serialization - Connected
Support Guide for Codification of Medicines
Support Guide for Codification of Medicines To comply with RDC 54/2013 (Version 2) Support: Introduction... 3 Expected Benefits... 3 Applications... 4 Secondary Packaging:... 4 Identification: GTIN Codification:
The Values & Benefits of Using a GDSNData Pool. Prepared by: Anthony Hayes Greg Patterson
The Values & Benefits of Using a GDSNData Pool Prepared by: Anthony Hayes Greg Patterson October 2014 Company Overview Around the world 5 Corporations: USA, Canada, Australia, France, Brazil,(Taiwan-Partner)
Impact of Serialization on Supply Chain
Impact of Serialization on Supply Chain Agenda Introduction What is serialization? Why required? Key developments international legislation and regulation Break Impact of serialization in supply chain
Hong Kong s public hospitals?
How to improve the patient care and medication management process what are we doing in Hong Kong s public hospitals? S C CHIANG BPharm (Hons), MRPS, MHA, FHKCHSE, FACHSE Senior Pharmacist Hospital Authority
Master Data Management Architecture
Master Data Management Architecture Version Draft 1.0 TRIM file number - Short description Relevant to Authority Responsible officer Responsible office Date introduced April 2012 Date(s) modified Describes
Business Process Map of GDSN Healthcare Attributes to Hospital Processes
Business Process Map of GDSN Healthcare Attributes to Hospital Processes About GS1 GS1 is a neutral, not-for-profit organization dedicated to the design and implementation of global standards and solutions
Biorepository and Biobanking
Biorepository and Biobanking LabWare s solution for biorepositories and biobanks combines powerful specimen tracking and logistics capabilities with specimen processing and workflow management features.
HHSL Barcode Guidelines Version 1.0 - September 2, 2014 HHSL Barcode Guidelines Version 1.0 - September 2, 2014 Page #1 of 14
Table of Contents HHSL Barcode Guidelines Version 1.0 - September 2, 2014 HHSL Barcode Guidelines Version 1.0 - September 2, 2014 Page #1 of 14 Table of Contents Table of Contents: Page # BARCODE GUIDELINES...
How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters
environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing
Drug Distribution Management Policy in Korea
Drug Distribution Management Policy in Korea Regarding introduction of Drug Serial Number System (Serialization) Ministry of Health and Welfare Drug Distribution Management Policy Overview Policy Objectives
Imperative. Tim Mohn Industry Principal Sparta Systems
Enterprise Level ChangeControl: Control: A Life Science Business Imperative Tim Mohn Industry Principal Sparta Systems Agenda GlobalChange Control: An Overview Benefits and Challenges Change Control as
Managed Services Overview
Managed Services Overview By Shyam Chodapunedi Company Overview 2 About KPIT 8300+ EMPLOYEES $410M REVENUE INDUSTRY FOCUSED GLOBAL PRESENCE Recognized Leader Enterprise IT Business Consulting Product Engineering
Position Paper (II) Healthcare Provider Advisory Council Implementation in hospitals hindered by bar code symbol issues
I. Introduction Towards the end of 2011, GS1 Healthcare established the Healthcare Provider Advisory Council (HPAC) to be the forum for sharing and discussing the practical realities of implementation
Welcome to online seminar on. Oracle Agile PLM. Design to Release & Change Management. Presented by: Rapidflow Apps Inc.
Welcome to online seminar on Oracle Agile PLM Design to Release & Change Management Presented by: Rapidflow Apps Inc. September 2010 Agenda Agile PLM Overview Agile Product Lifecycle Management (PLM) Overview
How To Help The Global Healthcare User Group (Hug)
HUG Global Healthcare User Group - HUG GS1 s Brand Architecture 2 The global Healthcare User Group - HUG Mission: Lead the healthcare industry to the effective utilization and development of global standards
IMPLEMENTATION GUIDELINE
IMPLEMENTATION GUIDELINE Applying GS1 Standards to U.S. Pharmaceutical Supply Chain Business Processes T O S U P P O R T P E D I G R E E A N D T R A C K & T R A C E Release 1.0 (February, 2013) Future
KICK-START CLOUD VENTURES
Contents SALESFORCE & CRM PRACTICE GROUP 3 MARKETING & CAMPAIGN MESSAGE ORCHESTRATION 4 FORCE.COM & ISV PARTNER INTEGRATED COLLABORATION & CAMPAIGN MANAGEMENT 4 MARKETING & OPERATIONAL MESSAGE ORCHESTRATION
Extemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
Coding and Labeling of Medical Devices Using ISBT 128
ISBT 128 STANDARD Coding and Labeling of Medical Devices Using ISBT 128 Version 1.4.0 October 2015 Tracking Number ICCBBA ST-011 ISBN-13: 978-1-933243-56-6 ISBN-10: 1-933243-56-2 Published by: ICCBBA PO
Clarity Infrastructure Management helps network operators to plan and document the change to their networks
Clarity Infrastructure Management helps network operators to plan and document the change to their networks clarity.com 2 Clarity Simplifying Operations Cost effective and timely network rollouts or upgrades
EAM RFID SOLUTIONS INTERNAL USE CASE A COMPLETE SOLUTION. ENHANCING EFFICIENCY + CUSTOMER SATISFACTION. THE CHALLENGE: PROCESS + PRODUCT THE COMPANY
INTERNAL USE CASE EAM RFID SOLUTIONS A COMPLETE SOLUTION. ENHANCING EFFICIENCY + CUSTOMER SATISFACTION. THE COMPANY EAM Worldwide, an OEM of aviation life vests and life rafts, operates a 56,000 square
The Drug Supply Chain Security Act: Readiness and Implementation Update
The Drug Supply Chain Security Act: Readiness and Implementation Update Connie Jung, RPh, PhD U.S. Food and Drug Administration Center for Drug Evaluation and Research Office of Compliance Office of Drug
IUID ASSET TRACKING FOR DEFENSE CONTRACTORS
IUID ASSET TRACKING FOR DEFENSE CONTRACTORS TRACK WHAT YOU HAVE AND COMPLY WITH DoD IUID STANDARDS FOR TOTAL CONTRACT FULFILL A2B provides full item lifecycle management systems that enable asset visibility
Clinical Data Management BPaaS Approach HCL Technologies
Leading pharmaceutical companies are estimating new business models including alternative Clinical data management platforms to reduce costs, shorten timelines, and maintain quality and compliance. HCL
Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
APX VCS Registry Operating Procedures. September 2012
APX VCS Registry Operating Procedures September 2012 Table of Contents 1 INTRODUCTION... 1 1.1 ABOUT THE APX VCS REGISTRY... 1 1.2 GEOGRAPHIC SCOPE... 1 2 ACCOUNTS AND USER REGISTRATION... 2 2.1 PARTICIPATION
Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
Aesculap Service Systems instacount PLUS. The new standard in instrument management
Aesculap Service Systems instacount PLUS The new standard in instrument management A pioneer in Instrument Management In 1986, Aesculap was the first company to develop and introduce an instrument management
Identification of Medicinal Products (IDMP) What is necessary in order to be compliant in 2016 and beyond?
Identification of Medicinal Products (IDMP) What is necessary in order to be compliant in 2016 and beyond? February 2015 Audit. Tax. Consulting. Corporate Finance. New ISO standards have been developed
Stock Management Methods in SAP: Some distinctive differences between IM, WM, and EWM
Stock Management Methods in SAP: Some distinctive differences between IM, WM, and EWM John Gardner [ CHAVONE JACOBS ASUG INSTALLATION MEMBER MEMBER SINCE: 2003 [ ALLAN FISHER ASUG INSTALLATION MEMBER MEMBER
120: All You Need to Know About Implementing EDI Eduardo Valdes, Vilore Foods, Co., Inc. Bekki Windsperger, Best Buy Co., Inc.
120: All You Need to Know About Implementing EDI Eduardo Valdes, Vilore Foods, Co., Inc. Bekki Windsperger, Best Buy Co., Inc. Agenda Introductions All About Electronic Data Interchange (EDI) Why Do EDI
Background and Position on UPN Bar Coding of Medical/Surgical Products in Distribution and Patient Care
Background and Position on UPN Bar Coding of Medical/Surgical Products in Distribution and Patient Care This document describes the format intended for use between a supplier or packager of healthcare
